Anadys Pharmaceuticals, Inc.

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.4, 2003-07, pp. : 511-518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ovation Pharmaceuticals, Inc.

By Deutsch Barry

Pharmacogenomics, Vol. 3, Iss. 6, 2002-11 ,pp. : 839-841

Future Medicine

Access to resources Recommend Favorite

Genaissance Pharmaceuticals, Inc.

By Oestreicher Paul

Pharmacogenomics, Vol. 3, Iss. 2, 2002-03 ,pp. : 273-276

Future Medicine

Access to resources Recommend Favorite

Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeutics

By Keates Andrew C Fruehauf Johannes H Xiang Shuanglin Parker Peter D Li Chiang J

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 867-871

Future Medicine

Access to resources Recommend Favorite

Iconix Pharmaceuticals, Inc. – removing barriers to efficient drug discovery through chemogenomics

By Engelberg Alan

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 741-744

Future Medicine

Access to resources Recommend Favorite

Millennium Pharmaceuticals

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1605-1608

Informa Healthcare

Access to resources Recommend Favorite